ABBV BUE Week ended 24 Jul 2026

Weekly Investor Report

AbbVie Inc. · Healthcare · Drug Manufacturers - General

Open interactive chart View report data
Latest close 41,320 ARS
2.5% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 22.6% above the Trend Line and sits at 92.5% of its 52-week range. The latest completed week returned 2.5%, after a 7.3% four-week move. The latest news-sentiment score is 53/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal.

Setup score 56 out of 100
Latest Close 41,320 ARS 24 Jul 2026
1W Return 2.5% latest completed week
4W Return 7.3% short-term follow-through
12W Return 29.8% quarterly tape
Trend Breadth 69.2% 36 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 4-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 42.58% based on similar historical setup states.
  • 3 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.5% Latest completed week; four-week move 7.3%. Indicator stack 52/78 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 42.58% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 53/100 33 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 22.6% above the Trend Line and sits at 92.5% of its 52-week range. The latest completed week returned 2.5%, after a 7.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6512-week average 0.35

12-week confirmation

Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.65Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 7.3% over four weeks, 29.8% over 12 weeks, and 68.7% over one year. The current trend has remained active for 4 consecutive weeks.

Performance by holding period

1W2.5%
4W7.3%
12W29.8%
26W24.2%
52W68.7%
Active trend streak4 weeks
Active weeks in one year36
Trend breadth69.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.26Latest activity-pressure read.
Pressure change66.5%Four-week change in activity pressure.
Leadership0.67Latest relative-leadership reading.
RS change175.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 33 relevant articles.

8 positive · 23 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.2%Distance below the 52-week high.
13-week volatility6.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+17.5%Week of 26 Jun.
Worst week-6.8%Week of 20 Mar.
Latest week+2.5%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains9
Flat weeks0
Modest losses6
Sharp losses5
Recent vol6.1%13-week weekly-return volatility.
Base vol5.1%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew4.6% / -3.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape51/100

Trend, activity pressure, participation, and risk combine to a 51/100 tape read.

 Indicator analysis40/100

Latest 12-week confirmation: trend 4/12, activity pressure 7/12, relative leadership 3/12.

Activity pressure 0.65; 3 reversal markers Next-Week ExpectancyNegative 42.58%

Next-week expectancy is negative with a 42.58% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment53/100

Weighted news tone is neutral across 33 relevant articles.

What To Expect From AbbVie’s (ABBV) Q2 Earnings Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202641,320 ARS2.5%33,705 ARS23,108 ARS1.260.675.0KOn
17 Jul 202640,320 ARS4.8%33,463 ARS22,870 ARS1.341.057.4KOn
10 Jul 202638,457 ARS-5.8%33,291 ARS22,637 ARS1.12-5.862.4KOn
3 Jul 202640,841 ARS6.1%33,127 ARS22,416 ARS0.992.5011.7KOn
26 Jun 202638,497 ARS17.5%32,907 ARS22,180 ARS0.76-0.8826.0KOff
19 Jun 202632,776 ARS-3.3%32,773 ARS21,960 ARS0.36-19.73150Off
12 Jun 202633,891 ARS-1.3%32,868 ARS21,775 ARS0.22-18.55785Off
5 Jun 202634,340 ARS6.2%32,902 ARS21,584 ARS-0.14-10.383.2KOff
29 May 202632,340 ARS0.4%32,837 ARS21,390 ARS-0.62-17.715.2KOff
22 May 202632,200 ARS2.5%32,857 ARS21,208 ARS-0.85-8.7910.2KOff
15 May 202631,400 ARS4.9%32,972 ARS21,028 ARS-1.12-6.195.8KOff
8 May 202629,920 ARS-6.0%33,103 ARS20,852 ARS-1.20-12.285.3KOff
1 May 202631,840 ARS7.1%33,240 ARS20,687 ARS-1.14-8.646.4KOff
24 Apr 202629,720 ARS-2.3%33,368 ARS20,508 ARS-1.23-14.946.9KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.